63 related articles for article (PubMed ID: 26617404)
1. Cholesterol-rich lipid rafts are involved in neuropeptide FF anti-nociceptin/orphanin FQ effect.
Ding Z; Zajac JM
J Neurochem; 2016 Feb; 136(4):778-790. PubMed ID: 26617404
[TBL] [Abstract][Full Text] [Related]
2. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
Ozsoy HZ; Thakker DR; Standifer KM
Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
[TBL] [Abstract][Full Text] [Related]
3. GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.
Moulédous L; Froment C; Dauvillier S; Burlet-Schiltz O; Zajac JM; Mollereau C
J Biol Chem; 2012 Apr; 287(16):12736-49. PubMed ID: 22375000
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide FF receptors exhibit direct and anti-opioid effects on mice dorsal raphe nucleus neurons.
Ding Z; Zajac JM
Eur J Pharmacol; 2014 Oct; 740():271-6. PubMed ID: 25046840
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.
Wang YQ; Guo J; Wang SB; Fang Q; He F; Wang R
Peptides; 2008 Jul; 29(7):1183-90. PubMed ID: 18406009
[TBL] [Abstract][Full Text] [Related]
6. Role of nociceptin/orphanin FQ and nociceptin opioid peptide receptor in depression and antidepressant effects of nociceptin opioid peptide receptor antagonists.
Park JY; Chae S; Kim CS; Kim YJ; Yi HJ; Han E; Joo Y; Hong S; Yun JW; Kim H; Shin KH
Korean J Physiol Pharmacol; 2019 Nov; 23(6):427-448. PubMed ID: 31680765
[TBL] [Abstract][Full Text] [Related]
7. Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.
Collins LM; Dal Bo G; Calcagno M; Monzón-Sandoval J; Sullivan AM; Gutierrez H; Morari M; O'Keeffe GW
Mol Neurobiol; 2016 Dec; 53(10):7284-7297. PubMed ID: 26687234
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.
Mollereau C; Mazarguil H; Zajac JM; Roumy M
Mol Pharmacol; 2005 Mar; 67(3):965-75. PubMed ID: 15608144
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.
Zhang C; McDougall JJ
Br J Pharmacol; 2006 Aug; 148(7):938-46. PubMed ID: 16783411
[TBL] [Abstract][Full Text] [Related]
10. Orphanin FQ/nociceptin activates nuclear factor kappa B.
Donica CL; Ramirez VI; Awwad HO; Zaveri NT; Toll L; Standifer KM
J Neuroimmune Pharmacol; 2011 Dec; 6(4):617-25. PubMed ID: 21547539
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones.
Roumy M; Garnier M; Zajac JM
Neurosci Lett; 2003 Sep; 348(3):159-62. PubMed ID: 12932818
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cyclic AMP-dependent response element-binding protein (CREB) by the nociceptin/orphanin FQ in human dopaminergic SH-SY5Y cells.
Kim MS; Cheong YP; So HS; Lee KM; Son Y; Lee CS; Yun JS; Park R
Biochem Biophys Res Commun; 2002 Mar; 291(3):663-8. PubMed ID: 11855841
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
[TBL] [Abstract][Full Text] [Related]
14. Modulation by neuropeptide FF of the interaction of mu-opioid (MOP) receptor with G-proteins.
Kersanté F; Moulédous L; Zajac JM; Mollereau C
Neurochem Int; 2010; 56(6-7):768-73. PubMed ID: 20211672
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of orphanin FQ/nociceptin and its fragments.
Rossi GC; Leventhal L; Bolan E; Pasternak GW
J Pharmacol Exp Ther; 1997 Aug; 282(2):858-65. PubMed ID: 9262352
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin/orphanin FQ prevents the antinociceptive action of paracetamol on the rat hot plate test.
Sandrini M; Vitale G; Pini LA; Lopetuso G; Romualdi P; Candeletti S
Eur J Pharmacol; 2005 Jan; 507(1-3):43-8. PubMed ID: 15659293
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.
Moulédous L; Merker S; Neasta J; Roux B; Zajac JM; Mollereau C
Biochem Biophys Res Commun; 2008 Aug; 373(1):80-4. PubMed ID: 18544342
[TBL] [Abstract][Full Text] [Related]
19. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
[TBL] [Abstract][Full Text] [Related]
20. GIRK channel-mediated inhibition of melanin-concentrating hormone neurons by nociceptin/orphanin FQ.
Parsons MP; Hirasawa M
J Neurophysiol; 2011 Mar; 105(3):1179-84. PubMed ID: 21191090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
